Trump Imposes New Tariffs on Certain Pharmaceutical Drugs

The executive order could slap tariffs of up to 100% on some patented drugs from companies that don't reach deals with the administration.

Apr. 3, 2026 at 12:21pm

Got story updates? Submit your updates here. ›

A close-up painting of a solitary pill bottle on a wooden table, with warm light and deep shadows creating a contemplative, nostalgic mood around the pharmaceutical product.As the Trump administration ramps up tariffs on imported drugs, the future of affordable pharmaceutical access remains uncertain.Alexandria Today

President Donald Trump signed an executive order that could impose tariffs of up to 100% on some patented drugs from pharmaceutical companies that don't reach pricing deals with his administration. Companies that sign a 'most favored nation' pricing agreement and commit to building drug manufacturing facilities in the U.S. will be exempt from the tariffs.

Why it matters

The new tariffs are part of Trump's ongoing trade war and efforts to lower drug prices in the U.S. However, the pharmaceutical industry warns the tariffs could increase costs for consumers and jeopardize investments in domestic drug production.

The details

The executive order gives companies 120 days (for larger firms) or 180 days (for everyone else) to negotiate pricing deals with the administration before the 100% tariffs kick in. Companies that sign a 'most favored nation' pricing agreement and commit to building drug manufacturing facilities in the U.S. will have a 0% tariff. Those without a pricing deal but building U.S. facilities will face a 20% tariff that will increase to 100% in four years.

  • The executive order was signed on Thursday, April 3, 2026.
  • The 100% tariffs will take effect 120-180 days after the order, depending on company size.

The players

President Donald Trump

The President of the United States who signed the executive order imposing the new pharmaceutical tariffs.

Stephen J. Ubl

CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade group that warned the tariffs could increase costs and jeopardize U.S. investments.

Got photos? Submit your photos here. ›

What they’re saying

“Taxes 'on cutting-edge medicines will increase costs and could jeopardize billions in U.S. investments.”

— Stephen J. Ubl, CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)

What’s next

Companies have 120-180 days to negotiate pricing deals with the administration before the 100% tariffs take effect.

The takeaway

The new pharmaceutical tariffs are the latest escalation in President Trump's trade war, as he continues to use import taxes to try to lower drug prices and bring more drug manufacturing to the U.S. However, the industry warns these tariffs could backfire and hurt consumers and investments.